At Wilmington Gastroenterology Associates, we participate in clinical trials that can potentially help our patients access novel treatments or improve healthcare outcomes. We have enrolled patients in clinical studies focusing on inflammatory bowel disease, colon cancer screening, liver disease, and more. We continue to seek out clinical studies to ultimately improve patient care, and partner with Innovo Research to conduct these studies.

Patient participation is an important aspect of clinical trials. By enrolling in a clinical trial, you can help yourself and millions of patients around the world by helping to advance the development of new treatments. Often compensation is provided for time and travel.

Currently, we are actively enrolling patients in a clinical study for metabolic dysfunction-associated steatohepatitis (MASH or MASLD, more commonly known as fatty liver disease).  If you are interested in learning more, please contact our office at (910)-362-1011.